無料セミナー : 2018年10月23日『5G、OTTがもたらすデジタルトランスフォーメーション2025年までの展望』 IDATE DigiWorld共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

DNAシークエンシング用モバイルアプリケーションの世界市場

Mobile Apps for DNA Sequencing: Global Markets

発行 BCC Research 商品コード 603505
出版日 ページ情報 英文 192 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.36円で換算しております。
Back to Top
DNAシークエンシング用モバイルアプリケーションの世界市場 Mobile Apps for DNA Sequencing: Global Markets
出版日: 2018年02月08日 ページ情報: 英文 192 Pages
概要

世界のDNAシークエンシング用モバイルアプリケーションの市場は予測期間中53.8%のCAGR (年間複合成長率) で推移し、2017年の288億ドルから、2022年には2483億ドルの規模に成長すると予測されています。

当レポートでは、世界のDNAシークエンシング用モバイルアプリケーションの市場を調査し、市場の定義と概要、DNAシークエンシング・専用モバイルアプリケーション・関連デバイスの各種技術の動向、関連プロジェクト・プログラム、主要事業者・研究機関・大学などの取り組み、技術・用途・地域別の市場成長予測、市場機会の分析などをまとめています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 概要

  • DNAシークエンシング技法
  • エピゲノミクス
  • プロモーター
  • エンハンサー
  • エンハンサーシーケンス
  • 整列化フローセル (Illumina)
  • ビーズ
  • DNAポリメラーゼ
  • ポリメラーゼプライマー
  • 遺伝子
  • 遺伝子転写・翻訳
  • InvFESTデータベース
  • 一分子リアルタイムシーケンシング (SMRT)
  • 遺伝子同定
  • ゲノム
  • シーケンシングアセンブリ
  • 構造的変異
  • 染色体逆位
  • 均衡型転座
  • メイトペアシーケンス
  • 全ゲノムシーケンシング
  • トランスクリプトームシーケンシング
  • De Novoシーケンシング
  • mAbの抗体タンパク質シーケンシング
  • フェージングシーケンシング
  • ジェノタイピング
  • フェノタイピング
  • De Novo/微生物全ゲノムシーケンシング
  • シーケンシング手法
  • 遺伝子発現プロファイリング
  • イントロン
  • 細胞質
  • 細胞分裂
  • エキソン配列
  • メッセンジャーRNA
  • マイクロRNA
  • SNPアレイ
  • マイクロアレイベースのジェノタイピング
  • シーケンシングデータ分析
  • ゲノミクス企業、など

第4章 プログラム・プロジェクト・開発動向

  • 背景
  • Illumina
  • ゲノミクスアプリ市場
  • 近年の発展動向
  • ゲノミクス技術
  • ゲノミクス機関・プログラム・リソース
  • ジェネラライズドゲノミクス
  • 研究象の遺伝子疾患
  • 関連イベント
  • 関連センター・関連機関、など

第5章 市場および技術の背景

  • クローニング
  • PCR (ポリメラーゼ連鎖反応)
  • キャピラリーシーケンシング
  • TCGA (The Cancer Genome Atlas):DNAシークエンシングアプリ
  • ICGC (International Cancer Genome Consortium)
  • GA4GH Beacon Project
  • ISB-CGC
  • Cancer Genome Project
  • Sequel (BioPac)
  • CNV (Copy Number Variation)
  • 全エクソームシーケンシング
  • ファイバー気管支鏡
  • プラスミドDNA
  • Base Pair (BP)
  • Unnatural Base Pair (UBP)
  • 精密医療
  • Health Data Compass
  • Tableau
  • Rapid Project (英国)
  • IGSR (The International Genome Sample Resource)
  • 利用可能な遺伝子検査タイプ
  • DNAシークエンシング用デバイス
  • ウェブアプリケーション
  • コンピュテーショナルバイオロジー/バイオインフォマティクス
  • ゲノミクス用ソフトウェア、など

第6章 市場分析:技術タイプ別

  • シーケンサー
  • DNA表現型解析
  • NimbleGen
  • MasterPure
  • Illumina
  • タブレット
  • 2G・3G・4G Androidスマートフォン
  • モバイルアプリ
  • コンピュテーショナルバイオロジー/希少疾患用デバイス、など

第7章 市場分析:エンドユーズ別

  • 遺伝子系譜
  • Invitae
  • IBM
  • Illumina
  • ClinicalTrials.gov
  • ALCHEMIST
  • 男性因子不妊症の遺伝子検査
  • ISB-CGC、など

第8章 市場分析:地域別

  • ESMO (European Society for Medical Oncology)
  • 新興市場

第9章 特許レビュー/新たな発展

第10章 市場機会の分析

  • 拡大する市場
  • ゲノミクスにおける液体取り扱いロボット/オートメーション
  • GEPベースの診断・予後・予測分類子
  • Googleクラウドプラットフォーム
  • Tableau
  • Syapse Interface
  • 精密医療データプラットフォーム、など

第11章 企業プロファイル

付録

BCC Researchについて

図表

List of Tables

  • Summary Table: Global Market for Mobile Applications of DNA Sequencing, by End Use, Through 2022 ($ Millions)
    • Table 1: Global Market for Mobile Applications of DNA Sequencing in Genealogy, Through 2022 ($ Millions)
    • Table 2: Global Market for Mobile Applications of DNA Sequencing in Computational Biology/Rare Diseases, Through 2022 ($ Millions)
    • Table 3: Global Market for Mobile Applications of DNA Sequencing, by Region, Through 2022 ($ Millions)
    • Table 4: Global Market Shares of Mobile Applications of DNA Sequencing, by Region, 2022 (%)
    • Table 5: Global Market for Mobile Applications of DNA Sequencing, by End Use, Through 2022 ($ Millions)
    • Table 6: Global Market for Mobile Applications of DNA Sequencing for Genealogy, by Region, Through 2022 ($ Millions)
    • Table 7: Global Market for Mobile Applications of DNA Sequencing in Computational Biology/Rare Diseases, by Region, Through 2022 ($ Millions)
    • Table 8: Review of Mobile Patents and Patent Applications of DNA Sequencing, 2014--Sept. 2017
    • Table 9: Abbreviations Used in Mobile Applications of DNA Sequencing
    • Table 10: Glossary of Terms Used in Mobile Applications of DNA Sequencing
    • Table 11: Report Sources

List of Figures

  • Summary Figure: Global Market for Mobile Applications of DNA Sequencing, by End Use, 2016-2022 ($ Millions)
    • Figure 1: Global Market for Mobile Applications of DNA Sequencing in Computational Biology/Rare Diseases, 2016-2022 ($ Millions)
    • Figure 2: Global Market for Mobile Applications of DNA Sequencing, by Region, 2016-2022 ($ Millions)
    • Figure 3: Global Market for Mobile Applications of DNA Sequencing, by End Use, 2016-2022 ($ Millions)
    • Figure 4: Global Market for Mobile Applications of DNA Sequencing in Computational Biology/Rare Diseases, by Region, 2016-2022 ($ Millions)
目次
Product Code: BIO156A

Report Highlights

The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.

Report Includes:

  • An in-depth analysis of the mobile applications of DNA sequencing, which is a developing personalized healthcare technique with enormous market potential.
  • Analyses of market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • A look at the current and future expectations regarding the cost of individual DNA mapping procedures
  • Quantification of the DNA sequencing markets by product type, indication, and geography
  • Insight into developers of apps, and how DNA mapping and apps combine to produce modern ways of recording information
  • Comprehensive discussion covering DNA sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
  • Patent analysis
  • Company profiles of major players in the DNA sequencing sector, including 23andMe, Helix, Illumina, Thermo Fisher Scientific, and Roche

Report Scope

This report is a comprehensive business tool, designed to provide an in-depth look at mobile applications of DNA sequencing. The geographical scope of the report is global, with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare sector and its participants and trends for the future.

Areas discussed include current funding being provided by the National Institutes of Health (NIH) in the U.S. and the National Health Service (NHS) in the U.K., which are at the forefront of this developing market. Funding worldwide is discussed in this report, together with the thought processes behind applying precision medicine to healthcare services.

Clinical trials are discussed in the report, together with developing technologies, software and cloud data storage, which are driving the translational science market for future precision medicine healthcare.

Categories discussed in the report include applications of:

  • DNA sequencing/mapping.
  • Genome sequencing/mapping.
  • Gene sequencing/mapping.
  • Exome sequencing.
  • Metagenomics.
  • Targeted sequencing.

Devices for individual use, which in the main use Android or iOS operating systems, are discussed briefly. While the device market is not specifically part of this report, the developing technology will be used for the future of this market, including:

  • iPads.
  • PCs.

The end-use segments discussed in the report are:

  • Genealogy.
  • Computational biology/rare diseases.

Categories, platform segments and regions are discussed in detail, including describing and identifying current products on the market, measuring the market size, and market drivers with a forecast to 2022. Competitors are assessed, together with their respective market shares. For the country-level breakdown of segments, only the base year 2017 and projections to 2022 are indicated in the data in the tables. Year-to-year differences are considered as statistically insignificant.

The market evaluation in the study pertains to existing processes and/or devices used in the mobile application of DNA sequencing, and which have been developed and approved for human clinical use. The market size takes this into account. Options/upgrades or refurbished/remarketed equipment has not been accounted for in the quantitative estimates and forecasts provided in the study. Ancillary products and services also related to the application of DNA sequencing conditions are discussed. Metrics countrywide, using information at the country level to look at the dynamics and their impact on reviews and growth, are used. Interviews were used to confirm and/or adjust the U.S. market size and market share estimates, as well as formulating market projections.

This report concentrates on the processes behind DNA sequencing techniques and discusses the developers of DNA sequencing and mobile applications of DNA sequencing and the history, processes and future developments being used to create and develop mobile applications.

Included in the report is a general overview of the genetic processes and terms used in the main areas of genomic studies and preparations. The report provides an outline only of the main areas involved with DNA sequencing.

This is a new market moving forward into revolutionary global healthcare through precision medicine. This report therefore reflects the new apps that have just become available in the market, together with developing technology. Clinical trials pertaining to moving toward the new global healthcare of precision medicine is studied in this report.

Included in the report is the developing market in the bioinformatics field of genetics and translational medicine from current standard medical practices to medical practices involving computational biology. Some devices studied in the report touch on the current and future market. The devices forecasted in the report are those that pertain to the current developing mobile apps market.

Specifically excluded from the study, as it is considered beyond the scope of the report, is an in-depth study of individuals who have had their DNA sequenced or mapped. Also excluded from the report is a detailed, in-depth study of the types of technology and methodology and terminology used, although this is outlined in general. Also excluded from the report is a detailed study of all the processes involved in genetics/genomes/sequencing as this topic is too vast in itself to explore in this report.

Also excluded from the report is a detailed description of all types of DNA sequencing, although the main areas in this topic are discussed, a further detailed in-depth examination of DNA sequencing is not deemed to be necessary for market values.

Considered outside the scope of this report is a detailed study of current mobile device technology, such as Android phones, PCs or tablets, as this report does not concentrate on this side of technological developments.

Analyst Credentials

The analyst of this report, Smruti Munshi, has specialized in the medical technologies space for more than five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking, and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets, ranging from market insights, industry overviews to comprehensive marketing and technology-oriented custom consulting. Ms. Munshi has an MS in Biomedical Engineering and a BS in Instrumentation and Control Engineering. She has authored several reports for BCC Research in the medical field.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Overview

  • DNA Sequencing Techniques
    • Genome Sequencing/Whole Genome Sequencing
    • Exome Sequencing/Targeted Sequencing
    • Proteomics
    • Metagenomics
    • Earth Microbes
    • Human Health Microbes
    • Research into Metagenomics
  • Epigenomics
    • History of the Development of Epigenomics
    • DNA Methylation
    • Histones/Histone Modification
  • Promoters
  • Enhancers
  • Transcription Start Site
  • Enhancer Sequences
  • Enzyme/Chemical Fragmentation of Proteins
  • Patterned Flow Cells (Illumina)
  • Beads
  • DNA Polymerase
    • Polymerase Primers
  • Genes
    • Heritable Genetic Disorders
  • Gene Transcription/Translation
    • Nucleotides
    • Non-Coding RNA (ncRNA)
    • Cellular Process Regulation
    • Chromatin Dynamics/Transcription
    • Gene Splicing
    • Cell Cycle Progression
    • Differentiation
    • DNA Repair
    • Nuclear Import
    • Capillary Sequencing
    • Next Generation Sequencing (NGS)
    • Molecular Pathology Nodes
  • Novel Structural Variants (SVs)
  • Watterson's Estimator
  • InvFEST Database
  • Single Molecule, Real-time Sequencing (SMRT)
  • Zero-Mode Waveguides
  • Phospholinked Nucleotide
  • Gene Identification in Genomes
  • Genomes
  • Expression Quantitative Trait Loci (eQTL)
  • Yeast Strains
  • Polygenic Diseases
  • Sequencing Assembly
  • Structural Variation
  • Chromosome Inversions
  • Balanced Translocations
  • Genomic Imbalances
  • Long-insert Pair-End Reads (Paired-End Sequencing)
  • Mate Pair Sequencing
  • Whole Genome Sequencing
    • Large Whole Genome Sequencing
    • Small Whole Genome Sequencing
    • Trio Analysis
    • Phased Sequencing/Genome Phasing
    • Cancer Whole Genome Sequencing (WGS)
    • Microbial Whole Genome Sequencing
    • Microbial Whole Genome Resequencing
    • De Novo Microbial Genome Sequencing
  • Transcriptome Sequencing
    • DNA Extraction
    • Library Preparation
    • Desktop Sequencing Systems
  • Scaffolds
  • Assemblies
    • Alternate Locus
    • Building Assemblies
  • Haplotyping
    • Whole Genome Haplotyping
  • De Novo Sequencing
    • Antibody De Novo Sequencing
    • Amplicon Sequencing
    • Isotopes
    • Idiotypes
    • Epitopes
    • Allotypes
  • Antibody Protein Sequencing of mAbs
  • Phased Sequencing
    • Alleles
    • Genetic Disorders
  • Genotyping
  • Phenotyping
  • Translational Research/Translational Science
  • CIS/Trans Position
  • Compound Heterozygotes
  • De Novo/Microbial Whole Genome Sequencing
    • De Novo Microbial Genome Sequencing
    • Microbial Whole Genome Resequencing
  • Sequencing Method Explorer
  • Gene Expression Profiling (GEP)
  • Introns
  • Cytoplasm
  • Cell Division
  • Exon Sequences
  • Messenger RNAs
  • Micro RNAs
  • SNP Arrays
  • Target-enriched Strategies
  • In-solution Capture
  • Microarray Based Genotyping
  • Sequencing Data Analysis
  • Genomics Companies

Chapter 4: Programs, Projects and Developments

  • Background
  • Illumina
  • Genomics Apps Marketplace
    • Helix App Store
    • Genealogy App-National Geographic's Geno 2.0 Test
    • 23andMe/AncestryDNA-Rthm-Sleep App
  • Recent Developments
    • SlumberType-Exploragen
    • 23andMe-FDA Approval
  • Genomics Techniques
    • Shotgun Metagenomics
  • Genomics Institutes, Programs and Resources
    • Orphanet
    • ClinicalTrials.gov (U.S.)
    • California Initiative to Advance Precision Medicine (CIAPM)
    • UCSF Clinical Microbiology Laboratory
    • The National Academy of Sciences (NAS)
    • Genome.One (Australia)
    • PathoQuest
    • University of Utah
    • Biology of Genomes Meeting
    • Human Genomes Project-25th Anniversary
    • 1,000 Genomes Project
    • National Precision Medicine Research Program
    • All of Us Research Program
    • University of Glasgow (Purpose Built Lab)
    • Scottish Precision Medicine Ecosystem
    • Cloudera
    • International HapMap Project
    • PMI Cohort Program
    • United Kingdom £300 Million Human Genome Project
    • British Society for Genetic Medicine (BSGM)
    • Genomics England
    • Medical Research Council Strategic Plan
    • Efficacy and Mechanism Evaluation Program
    • NIHR Evaluation, Trials and Studies Coordinating Centre
    • Health Technology Assessment Program
    • National Center for Advancing Translational Sciences (NCATS)
    • CCPM (Colorado Center for Personalized Medicine)
  • Generalized Genomics
    • Novel Therapeutics Technology Inc. (NTT)
    • ISQ EC Single Quadruple Mass Spectrometer (MapPac RM 1MM Columns)
    • HTG EdgeSeq PATH Assay
    • Innovator's Edge
    • Pneumonia Diagnostics Study, U.K. (Inhale Project)
  • Genetic Diseases Being Researched
    • CHAPLE Syndrome/Rare Gut Diseases
    • Trio Analysis
  • Events in Genomics
    • Illumina's New Chief Executive-2017
    • Oxford Nanopore Technologies-Illumina Litigation
    • AStar Singapore
  • Specialized Genomic Centers/Related Institutes
    • Pfizer's Centers for Therapeutic Innovation (CTI)
    • Rare Diseases Clinical Research Network (RDCRN)
    • Small Business Innovation Research (SBIR)
    • Small Business Technology Transfer (STTR)
    • Therapeutics for Rare and Neglected Diseases (TRND)
    • Tissue Chip for Drug Screening
    • Toxicology in the 21st Century (Tox21)
    • NCATS Center Organization
    • NIHR
    • Centers for Mendelian Genomics (CMG)-U.K.
    • National Human Genome Research Institute (NIH)-U.S.
    • UCSF Abbot Viral Diagnostic and Discovery Center (VDDC)-China
  • DNA Sequencing Devices
    • SlumberType-Exploragen
    • Rthm-23andMe
    • DeepHeart Technology
    • Personalized Exercise Plans
    • Sleep Easy
  • Generalized Genomics
    • Orphanet Journal of Rare Diseases
    • Human Phenotype Ontology (HPO)
    • U.S. National Library of Medicine
    • Cloudera
    • PMI Cohort Program

Chapter 5: Market and Technology Background

  • Cloning
    • DNA Sequencing Technologies
    • 454 Sequencing
  • PCR (Polymerase Chain Reaction)
  • Capillary Sequencing
  • TCGA (The Cancer Genome Atlas)-DNA Sequencing App
  • International Cancer Genome Consortium (ICGC)
  • GA4GH Beacon Project
  • ISB Cancer Genomics Cloud (ISB-CGC)
  • Cancer Genome Project
  • Sequel (BioPac)
  • Methylation and Uracil Interference Assay Methods
    • Methylation Interference
    • Uracil Interference
  • Copy Number Variations
  • Whole Exome Sequencing
  • Fiberoptic Bronchoscopy
  • Plasmid DNA
  • Base Pair (BP)
  • Unnatural Base Pair (UBP)
  • MSK-Impact Test
  • Gene Chip
  • Healthcare Regulations in the U.S.
  • Precision Medicine
  • Health Data Compass
  • Tableau
  • Rapid Project (U.K.)
  • The International Genome Sample Resource (IGSR)
  • Types of Genetic Tests Available
  • Genetic Test Register (GTR)-NIH
  • UK10K
  • Devices Used for DNA Sequencing
    • Mobile Phone Development
    • Cellular Mobile Phones
    • Desktop Personal Computers
    • Tablets
  • Web-based Applications
    • RIM
    • Android
    • Mac OS (Mac Operating System)
    • Symbian
    • Windows Mobile
  • Sales of Mobile Devices
    • Windows Phone
    • Windows 10
  • Computational Biology/Bioinformatics
    • Mathematical Modeling
  • Software for Genomics
    • Illumina
    • Pacific Biosciences (PacBio)
  • NCI Precision Medicine Initiative
    • Lung Cancer Master Protocol (Lung-MAP)
    • Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST)
    • Molecular Profiling-Based Alignment of Cancer Therapy (NCI-MPACT)
    • Lung-Map (Lung Cancer Master Protocol)
    • NCI-COG Pediatric MATCH
    • Exceptional Responders Study (Phenotype to Genotype Trial)
  • FDA Clearance (510K) Procedures for Medical Devices
  • Reducing Prices

Chapter 6: Market Breakdown by Technology Type

  • Sequencers
    • NextSeq 500
    • NextSeq 550
    • NovaSeq 5000
    • NovaSeq 6000
    • MiSeq
    • MiSeqDx
    • HiSeq X Sequencing
  • Snapshot DNA Phenotyping
  • NimbleGen Sequencing Capture Microarrays and Services
  • MasterPure Complete DNA/RNA Purification Kit-Illumina
  • Base Space-Illumina
    • BaseSpace Correlation Engine
    • BaseSpace Variant Interpreter
    • SOLiD Sequencing (Thermo Fisher)
  • Tablets
  • 2G, 3G and 4G Android “Smart” Phones
  • Mobile Apps
    • Genealogy Apps and Websites
    • Other Genealogy Companies
    • Computational Biology/Rare Diseases
    • Software for Mobile Apps
  • Computational Biology/Rare Diseases-Devices
    • MinION
    • GridION
    • PromethION
    • Sequel
    • SlumberType App-Exploragen
  • NIH (U.S.) Grants for Computational Biology/Bioinformatics
  • General Genomic Device Information
    • Forward and Reverse Reads in Paired-End Sequencing-Device Usage
    • Patterned Flow Technology-Illumina
    • QiaSymphony Platform (CMV Assay)
    • Catalogue of Somatic Mutations in Cancer (COSMIC)
    • Membership in the GA4GH
  • Phenotyping Systems/Platforms

Chapter 7: Market Breakdown by End Use

  • Genealogy
    • National Geographic's Geno 2.0 test
    • Computational Biology/Rare Diseases
    • Background
    • Phased Sequencing
    • Human Whole Genome Phasing Solutions
    • Illumina Advanced Long-read Applications Solutions
    • Illumina Library Kits for Sequencing
  • Invitae
    • Helix App Store
  • IBM Container Service
  • IBM BlueMix
    • Kubernetes
    • API Connect
    • Cloud Foundry Apps
    • IoT Platform
    • Watson Personality Insights
    • Watson Language Translator
    • Cloudant NoSQL DB
    • Watson Tone Analyzer
    • Watson Conversation
    • Mobile Push Notifications
  • BaseSpace-Illumina
  • BaseSpace Variant Interpreter for Cancer Samples-Illumina
  • ClinicalTrials.gov
  • ALCHEMIST (Adjuvant Lung Cancer Enrichment Market Identification and Sequencing Trials)
  • Isaac Whole Genome Sequencing v2 (Illumina)
  • Male Factor Infertility Genetic Tests
    • Karyotype
    • Y Chromosome Microdeletion Test
    • Cystic Fibrosis Gene Test
    • Klinefelter Syndrome
    • Y Chromosome Microdeletion
    • Chromosome Abnormalities
  • ISB Cancer Genomics Cloud (ISB-CGC)
    • FamilySearch
    • Computational Biology/Rare Diseases

Chapter 8: Market Breakdown by Region

  • European Society for Medical Oncology (ESMO)
  • Emerging Markets
    • China
    • Singapore
    • Computational Biology/Rare Diseases

Chapter 9: Patent Review/New Developments

  • New Developments
    • Proactive Genetic Health Applications
    • ECRIgene
    • Beamsplitter/Silicon Photonics
    • Apache Hadoop
    • Mobile PGx Platform-Rennova Health
    • ThyraMIR Assay
    • Nanopore Sequencing
    • Solid State Nanopores-NGS Sequencing
    • Hybrid Nanopores
    • Integrated Sensor Nanopores
    • Helix App Store

Chapter 10: Analysis of Market Opportunities

  • Expanding Market
    • Next Generation Sequencing (NGS)
    • Illumina (Solexa) Sequencing
    • Roche 454 Sequencing
    • Ion Torrent Proton/PGM Sequencing
    • All of Us Research Program
    • Cell Free Fetal DNA Test (cfDNA)
    • NIPT (Noninvasive Prenatal Testing)
    • RNA Sequencing-Next-generation Sequencing (NGS)
    • Variants-Prostate Cancers
  • Liquid Handling Robots/Automation in Genomics
  • GEP-Based Diagnostic, Prognostic and Predictive Classifiers
  • Google Cloud Platform
    • Google App Engine
    • Google Cloud Datastore
    • Google Compute Engine
    • Google Cloud Storage
    • Google Cloud Pub/Sub
    • Google Cloud Functions
    • Google Container Engine
    • Google Compute Engine
    • Google Stackdriver
    • Google BigQuery
    • Google Cloud Datastore Calls
  • Tableau
  • Syapse Interface
  • Precision Medicine Data Platform
  • Social+Capital Partnership
  • SlumberType App-Exploragen-Helix App Store
  • Thermo Fisher-You Tube Advertising
  • DNA Testing Changes
  • Broad Institute
    • Helix App Store for DNA Sequencing
  • Development Opportunities
    • BioMerieux BacT/Alert Virtuo Receives FDA Clearance
  • Broad Institute
  • Invitae/Data Sharing

Chapter 11: Company Profiles

Appendix

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research
Back to Top